BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16834929)

  • 1. Therapeutic DNA vaccines against tuberculosis: a promising but arduous task.
    Li JM; Zhu DY
    Chin Med J (Engl); 2006 Jul; 119(13):1103-7. PubMed ID: 16834929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines for therapy of tuberculosis: where are we now?
    Lowrie DB
    Vaccine; 2006 Mar; 24(12):1983-9. PubMed ID: 16316711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
    Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z
    Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccines against mycobacterial diseases.
    Romano M; Huygen K
    Expert Rev Vaccines; 2009 Sep; 8(9):1237-50. PubMed ID: 19722896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
    Yu DH; Hu XD; Cai H
    Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis vaccines: past, present and future.
    Martin C
    Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
    Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
    J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis: vaccine and drug development.
    Mitsuyama M; McMurray DN
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S10-3. PubMed ID: 17616481
    [No Abstract]   [Full Text] [Related]  

  • 16. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUTI: a new chance to shorten the treatment of latent tuberculosis infection.
    Cardona PJ
    Tuberculosis (Edinb); 2006; 86(3-4):273-89. PubMed ID: 16545981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.
    Silva CL; Bonato VL; Coelho-Castelo AA; De Souza AO; Santos SA; Lima KM; Faccioli LH; Rodrigues JM
    Gene Ther; 2005 Feb; 12(3):281-7. PubMed ID: 15526006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis.
    Lalloo UG; Naidoo R; Ambaram A
    Curr Opin Pulm Med; 2006 May; 12(3):179-85. PubMed ID: 16582672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.